Filing Details

Accession Number:
0001209191-16-153167
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-02 18:47:05
Reporting Period:
2016-11-30
Filing Date:
2016-12-02
Accepted Time:
2016-12-02 18:47:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
924717 Surmodics Inc SRDX Surgical & Medical Instruments & Apparatus (3841) 411356149
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1412895 K Bryan Phillips 9924 West 74Th Street
Eden Prairie MN 55344
Svp, Gen Counsel & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-11-30 2,713 $0.00 29,170 No 4 A Direct
Common Stock Acquisiton 2016-11-30 4,881 $0.00 34,051 No 4 A Direct
Common Stock Disposition 2016-11-30 2,353 $23.95 31,698 No 4 F Direct
Common Stock Disposition 2016-12-02 1,264 $23.90 30,434 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 A Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (right to buy) Acquisiton 2016-11-30 17,121 $0.00 17,121 $23.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,121 2023-11-30 No 4 A Direct
Footnotes
  1. Performance shares awarded under long-term incentive plan based on performance during three-year period ended September 30, 2016.
  2. Shares withheld to satisfy taxes incident to vesting of performance share award.
  3. Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2016.
  4. Reflects the weighted average price of 1,264 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 2, 2016 with sale prices ranging from $23.75 to $24.075 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  5. The award vests in four equal installments on each of the first four anniversaries of the November 30, 2016 grant date.